News

Filter

1 to 9 of 96303 results

Long-acting insulin is safer, more effective for patients with type 1 diabetes

01-10-2014

Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with type…

DiabetesInsulin DetemirInsulin Glargine [rDNA origin] InjectionPharmaceuticalResearch

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

01-10-2014

French drug major Sanofi and US biotech company Regeneron's dupilumab has met all primary and secondary…

dupilumabFrancePharmaceuticalRegeneronResearchRespiratory and PulmonarySanofiUSA

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

01-10-2014

Data posters presented at this year’s European Society for Medical Oncology (ESMO) Congress in Madrid,…

EisaiHalavenJapanOncologyPharmaceuticalResearchSpain

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

ESMO 2014: AstraZeneca’s AZD9291 and Iressa

01-10-2014

The annual congress of the European Society for Medical Oncology (ESMO) came to a close in Madrid, Spain,…

AstraZenecaAZD9291IressaOncologyPharmaceuticalResearchUK

Diplomat pharmacy receives expanded FDA approval for Xtandi in metastatic prostate cancer

Diplomat pharmacy receives expanded FDA approval for Xtandi in metastatic prostate cancer

01-10-2014

Independent specialty pharmacy Diplomat has received expanded approval for Xtandi (enzalutamide) from…

Astellas PharmaDiplomatMedivationOncologyPharmaceuticalRegulationUSAXtandi

Eurofins Genomics expands business into Italy

Eurofins Genomics expands business into Italy

01-10-2014

Eurofins Genomics, the genomics division of Eurofins Scientific Group, has expanded its business into…

BiotechnologyEurofins GenomicsGeneticsItalyMarkets & Marketing

1 to 9 of 96303 results

Back to top